Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Mortgage Finance

Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; ...
Website: htgc.com


  • Good financial results growth rate 166.7% (average between last period year over year growth for revenue and Net Income), there is acceleration compared to average historical growth rates (56.8%)
  • Dividend yield for the last twelve months 11.6%
  • Share price is 6.7% higher than minimum and 26.5% lower than maximum for the last 3 years
  • The company is overvalued by P/E LTM multiple compared to target level (170.2x vs 30.0x)
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: HTGC
Share price, USD:  (-1.0%)16.16
year average price 17.46  


year start price 18.00 2025-11-09

max close price 19.04 2025-12-10

min close price 15.15 2026-06-03

current price 16.16 2026-11-08
Common stocks: 189 548 796

Dividend Yield:  11.6%
P / E LTM: 170.2x
P / E annualized: 8.6x
Last revenue growth (y/y):  +133.3%
Last growth of Net Income (y/y):  +200.0%
Historical revenue growth:  +47.7%
Historical growth of Net Income:  +65.9%
EV / Sales: 6.0x
Margin (Net Income LTM / Revenue): 3.6%

Target P/E (hist percentile): 30.0x
Express share price potential:
Fundamental value created in LTM:
P/E mutiple calculation
Market Cap ($m): 3 063
Net Profit ($m): 18
P / E LTM: 170.2x
Price to Book: 1.4x

Revenue and Net Income

Quarterly values ($m)

Change (y/y)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

P / E

Potential dynamics

News


2026-02-08seekingalpha.com

Hercules Capital: Why I Am Buying The Liberation Day-Like Collapse On Overblown AI Panic

2026-01-14zacks.com

Hercules Capital (HTGC) Rises As Market Takes a Dip: Key Facts

2025-12-29seekingalpha.com

Hercules Capital: Pay The BV Premium And Be Done With It

2025-12-26zacks.com

Hercules Capital (HTGC) Increases Despite Market Slip: Here's What You Need to Know

2025-12-24seekingalpha.com

Hercules Capital: Diamond In The Rough

2025-11-18seekingalpha.com

Hercules Capital: Opportunity Knocks On This 11% Yield

2025-11-09seekingalpha.com

Hercules Capital: Buy American Technology And Earn A 10.4% Dividend Yield For 2026

2025-10-31seekingalpha.com

Hercules Capital, Inc. (HTGC) Q3 2025 Earnings Call Transcript

2025-10-30zacks.com

Hercules Capital (HTGC) Q3 Earnings Miss Estimates

2025-10-26seekingalpha.com

Don't Just Seek Yield, Seek Durability: The Hercules Capital Story
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-30 2025-07-31 2024-10-30 2024-08-01 2024-05-02 2023-09-30 2023-08-03 2023-03-31 2022-11-02
acceptedDate 2025-10-30 16:17:32 2025-07-31 16:17:31 2025-02-13 16:16:42 2024-10-30 16:16:34 2024-08-01 16:16:37 2024-05-02 16:17:13 2024-02-15 16:17:43 2023-09-29 20:00:00 2023-08-03 16:18:26 2023-03-31 00:00:00 2023-02-16 16:08:16 2022-11-02 16:08:49 2022-02-22 16:31:34 2021-02-23 16:31:15
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 169M 128M 431M 119M 119M 130M 494M 51M 118M 118M 239M 73M 310M 357M
costOfRevenue 24M 23M 77M 12M 2M 3M 68M 3M 13M 0 55M 11M 54M 60M
grossProfit 145M 105M 354M 107M 117M 127M 426M 49M 105M 118M 185M 62M 255M 298M
grossProfitRatio 0.857 0.82 0.898 0.98 0.98 0.95 0.891 1 0.85
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 4M 5M 20M 5M 4M 5M 19M 5M 5M 4M 17M 4M 16M 19M
sellingAndMarketingExpenses 0 0 0 0 19M 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 4M 5M 20M 5M 4M 5M 19M 5M 5M 4M 17M 4M 16M 19M
otherExpenses 21M 21M 71M 28M 27M -19M 70M -67M 25M 19M 66M 15M 65M 52M
operatingExpenses 25M 26M 91M 32M 23M 19M 89M 24M 23M 23M 83M 20M 81M 71M
costAndExpenses 50M 49M 168M 44M 58M 21M 157M 24M 43M 23M 137M 36M 135M 130M
interestIncome 131M 130M 467M 119M 118M 116M 434M 110M 109M 100M 307M 81M 253M 263M
interestExpense 24M 23M 77M 20M 19M 18M 68M 16M 17M 17M 55M 14M 54M 60M
depreciationAndAmortization 84 000 81 000 466 000 91 000 96 000 186 000 190 000 59 000 64 000 44 000 204 000 50 000 317 000 415 000
ebitda 120M 79M 263M 89M 104M 109M 338M 28M 66M 111M 102M 137M 174M 228M
ebitdaratio 0.707 0.619 0.749 0.513 0.839 0.544 0.559 0.946 1.879
operatingIncome 120M 79M 263M 75M 61M 109M 337M 28M 66M 111M 102M 137M 174M 227M
operatingIncomeRatio 0.707 0.618 0.628 0.512 0.837 0.543 0.559 0.946 1.878
totalOtherIncomeExpensesNet 0 0 0 -6M -64M -18M 0 -16M 29M -17M 0 -84M 0 0
incomeBeforeTax 120M 79M 263M 69M 42M 91M 337M 28M 95M 95M 102M 53M 174M 227M
incomeBeforeTaxRatio 0.707 0.618 0.577 0.351 0.701 0.543 0.802 0.805 0.729
incomeTaxExpense 0 0 0 0 737 000 958 000 0 -16M -64 000 17M 0 -14M 0 0
netIncome 120M 79M 263M 68M 42M 91M 337M 28M 95M 95M 102M 53M 174M 227M
netIncomeRatio 0.707 0.618 0.571 0.351 0.701 0.543 0.802 0.805 0.729
eps 0.66 0.44 1.61 0.42 0.26 0.57 2.32 0.19 0.66 0.69 0.8 0.41 1.5 2.02
epsdiluted 0.63 0.43 0.42 0.25 0.57 0.19 0.66 0.68 0.41
weightedAverageShsOut 180M 177M 161M 161M 161M 157M 144M 147M 141M 135M 125M 127M 115M 112M
weightedAverageShsOutDil 194M 191M 162M 162M 161M 158M 145M 147M 142M 137M 127M 129M 116M 112M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link
filingDate 2025-02-13 2024-02-15 2023-02-16 2022-02-22 2021-02-23
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 390M 367M 253M 199M 204M
ebit 263M 337M 102M 174M 227M
nonOperatingIncomeExcludingInterest 0 0 0 0 0
netIncomeFromContinuingOperations 263M 337M 102M 174M 227M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 263M 337M 100M 174M 227M
epsDiluted 1.61 2.31 0.79 1.49 2.01

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-30 2025-07-31 2024-10-30 2024-08-01 2024-05-02 2023-09-30 2023-08-03 2023-03-31 2022-11-02
acceptedDate 2025-10-30 16:17:32 2025-07-31 16:17:31 2025-02-13 16:16:42 2024-10-30 16:16:34 2024-08-01 16:16:37 2024-05-02 16:17:13 2024-02-15 16:17:43 2023-09-29 20:00:00 2023-08-03 16:18:26 2023-03-31 00:00:00 2023-02-16 16:08:16 2022-11-02 16:08:49 2022-02-22 16:31:34 2021-02-23 16:31:15
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 29M 52M 113M 39M 39M 60M 99M 32M 62M 71M 16M 57M 133M 198M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 2 745M 0 0
cashAndShortTermInvestments 29M 52M 113M 39M 39M 60M 99M 32M 62M 71M 16M 2 802M 133M 198M
netReceivables 36M 35M 33M 31M 32M 35M 33M 32M 32M 31M 32M 25M 17M 19M
inventory 0 0 0 0 0 1 0 1 0 0 0 0 0 0
otherCurrentAssets 0 1M -70M 0 0 -96M 0 -69M 0 0 11M 0 4M 39M
totalCurrentAssets 66M 88M 75M 70M 59M 96M 132M 64M 94M 103M 58M 2 828M 154M 257M
propertyPlantEquipmentNet 15M 16M 17M 17M 18M 19M 5M 5M 4M 4M 5M 6M 7M 9M
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
goodwillAndIntangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
longTermInvestments 0 4 176M 3 660M 3 561M 3 569M 3 572M 3 248M 3 261M 3 113M 3 130M 2 964M 2 826M 2 435M 2 354M
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 0 4M -3 660M -3 561M -3 569M 10M 0 -3 266M -3 113M -3 135M 1M -2 826M 5M 4M
totalNonCurrentAssets 15M 4 196M 17M 17M 18M 3 600M 3 253M 3 266M 4M 3 135M 2 970M 6M 2 446M 2 367M
otherAssets 4 329M 0 3 740M 3 569M 3 595M 0 32M 6M 3 127M 15M 0 91M 0 0
totalAssets 4 410M 4 284M 3 832M 3 656M 3 672M 3 696M 3 417M 3 336M 3 225M 3 252M 3 029M 2 925M 2 600M 2 624M
accountPayables 0 52M 55M 47M 50M 39M 51M 46M 47M 33M 46M 34M 42M 36M
shortTermDebt 17M 101M 3M 0 0 2M 105M 367 000 4M 0 0 6M 379M 0
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 -50M 0 0 46M 0 0 0 0 0 0
otherCurrentLiabilities 0 507 000 -3M 0 106M -2M 2M -46M -47M -33M 0 -34M 0 0
totalCurrentLiabilities 17M 153M 55M 47M 19M 39M 158M 46M 4M 33M 48M 6M 427M 36M
longTermDebt 0 1 980M 1 769M 18M 0 1 752M 1 450M 1 638M 1 592M 1 719M 1 574M 1 527M 857M 1 287M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 2 204M 0 0 -18M 1 660M 19M 0 -1 638M 43M -1 686M 0 1 515M 0 0
totalNonCurrentLiabilities 2 204M 1 980M 1 787M 1 804M 1 797M 1 771M 1 453M 1 638M 1 635M 33M 1 580M 1 556M 864M 1 296M
otherLiabilities 0 0 0 -46M 0 0 3M 0 0 1 686M 0 0 0 0
capitalLeaseObligations 0 17M 15M 18M 0 18M 3M 5M 4M 0 6M 6M 7M 9M
totalLiabilities 2 220M 2 133M 1 842M 1 805M 1 816M 1 810M 1 614M 1 684M 1 639M 1 753M 1 627M 1 562M 1 291M 1 332M
preferredStock 0 0 0 0 0 1 0 0 0 0 0 0 0 0
commonStock 182M 182 000 171 000 163 000 163 000 163 000 158 000 152 000 145 000 139 000 134 000 131 000 117 000 115 000
retainedEarnings 0 54M 89M 110M 119M 155M 140M 73M 117M 90M 60M 74M 217M 133M
accumulatedOtherComprehensiveIncomeLoss 0 0 0 0 0 0 0 0 0 0 0 0 0 -0
othertotalStockholdersEquity 2 008M 2 097M 1 742M 1 737M 1 731M 1 579M 1 468M 1 409M 1 288M
totalStockholdersEquity 2 190M 2 151M 1 990M 1 852M 1 857M 1 886M 1 803M 1 652M 1 586M 1 499M 1 401M 1 363M 1 309M 1 292M
totalEquity 2 190M 2 151M 1 990M 1 852M 1 857M 1 886M 1 803M 1 652M 1 586M 1 499M 1 401M 1 363M 1 309M 1 292M
totalLiabilitiesAndStockholdersEquity 4 410M 4 284M 3 656M 3 672M 3 696M 3 336M 3 225M 3 252M 2 925M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 4 410M 4 284M 3 832M 3 656M 3 672M 3 696M 3 417M 3 336M 3 225M 3 252M 3 029M 2 925M 2 600M 2 624M
totalInvestments 0 4 176M 3 660M 3 561M 3 569M 3 572M 3 248M 3 261M 3 113M 3 130M 2 964M 2 826M 2 435M 2 354M
totalDebt 17M 2 081M 1 787M 18M 1 766M 1 771M 1 560M 1 638M 1 592M 1 719M 1 580M 1 527M 1 244M 1 296M
netDebt -13M 2 029M 1 674M -20M 1 727M 1 711M 1 461M 1 606M 1 531M 1 648M 1 564M 1 470M 1 111M 1 098M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link
filingDate 2025-02-13 2024-02-15 2023-02-16 2022-02-22 2021-02-23
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 33M 0 32M 17M 19M
otherReceivables 0 33M 0 0 0
prepaids 0 0 0 0 0
totalPayables 55M 51M 46M 42M 36M
otherPayables 0 0 0 0 0
accruedExpenses 0 0 1M 6M 0
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 15M 3M 6M 7M 9M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 1 900M 1 663M 1 341M 1 092M 1 158M
otherTotalStockholdersEquity 0 0 -0 -0 1

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC HTGC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-30 2025-07-31 2024-10-30 2024-08-01 2024-05-02 2023-09-30 2023-08-03 2023-03-31 2022-11-02
acceptedDate 2025-10-30 16:17:32 2025-07-31 16:17:31 2025-02-13 16:16:42 2024-10-30 16:16:34 2024-08-01 16:16:37 2024-05-02 16:17:13 2024-02-15 16:17:43 2023-09-29 20:00:00 2023-08-03 16:18:26 2023-03-31 00:00:00 2023-02-16 16:08:16 2022-11-02 16:08:49 2022-02-22 16:31:34 2021-02-23 16:31:15
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 119M 58M 31M 68M 41M 90M 337M 28M 95M 95M 102M 53M 174M 227M
depreciationAndAmortization 84 000 -48M 466 000 45M 96 000 186 000 190 000 59 000 64 000 44 000 6M 50 000 7M 415 000
deferredIncomeTax 0 0 0 0 0 0 0 -3M 0 0 0 0 0 -8M
stockBasedCompensation 0 4M 0 0 3M 3M 0 3M 0 0 13M 8M 12M 11M
changeInWorkingCapital 182 000 15M 15M -7M 14M -7M -17M 169 000 15M -11M -16M -7M 13M 6M
accountsReceivables -1M -2M 62 000 69 000 4M -3M 0 27 000 0 0 -14M 0 2M 1M
inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 -1M
accountsPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 -16 000
otherWorkingCapital 2M 17M 15M -7M 10M -4M -17M 142 000 0 0 -2M 0 12M 6M
otherNonCashItems -40M -174M -165M -27M 25M -15M -252M -144M 23M -165M -530M -108M -78M -26M
netCashProvidedByOperatingActivities 79M -145M -118M 79M 84M 65M 68M -115M 134M -81M -425M -53M 129M 208M
investmentsInPropertyPlantAndEquipment -29 000 0 -705 000 670 000 -378 000 -292 000 -887 000 -11 000 -285 000 -94 000 -114 000 -12 000 -106 000 -137 000
acquisitionsNet 0 0 0 0 0 0 0 0 0 0 0 0 0 137 000
purchasesOfInvestments -372M -557M -1 542M -225M -350M -605M 0 -457M 0 0 0 -1 098M 0 -761M
salesMaturitiesOfInvestments 290M -96M 1 005M 120M 326M 300M 0 268M 0 0 0 392M 0 33M
otherInvestingActivites 0 654M 104M 0 419M 189M 0 0 705M
netCashUsedForInvestingActivites -83M -19 000 -30 000 -25M -306M -11 000 -285 000 -94 000 -12 000
debtRepayment 85M 85M -9M -6M -196M -110M -282M -86M -24M
commonStockIssued -12 000 149M 0 0 66M 111M 66M 66M 43M
commonStockRepurchased -974 000 -1M -3M -1M 1M -3M -13M -512 000 -10M -1M -5M -572 000 -3M -2M
dividendsPaid -84M -81M -75M -76M -74M -71M -66M -64M -63M
otherFinancingActivites 0 -9M -2M -36 000 66M 149M 154M 219M 44M
netCashUsedProvidedByFinancingActivities 397 000 144M -87M -80M 185M 79M -138M 134M -83 000
effectOfForexChangesOnCash 0 0 0 0 0 0 0 0 0 0 0 0 0 0
netChangeInCash -3M -1M 408 000 5M -21M -56M 90M -37M -5M 53M -110M -53M -101M 123M
cashAtEndOfPeriod 50M 53M 116M 44M 39M 60M 116M 37M 74M 79M 26M 65M 136M 238M
cashAtBeginningOfPeriod 53M 54M 116M 39M 60M 116M 26M 74M 79M 26M 136M 119M 238M 115M
operatingCashFlow 79M -145M -118M 79M 84M 65M 68M -115M 134M -81M -425M -53M 129M 208M
capitalExpenditure -29 000 0 -705 000 -30 000 -378 000 -292 000 -887 000 -11 000 -285 000 -94 000 -114 000 -12 000 -106 000 -137 000
freeCashFlow 79M -145M -119M 93M 83M 65M 67M -115M 133M -81M -425M -53M 129M 208M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link
filingDate 2025-02-13 2024-02-15 2023-02-16 2022-02-22 2021-02-23
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 537M 0 0 0 728M
netCashProvidedByInvestingActivities -705 000 -887 000 -114 000 -106 000 -137 000
netDebtIssuance 214M -24M 343M -50M -3M
longTermNetDebtIssuance 214M -24M 343M -50M -3M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 217M -13M -5M -3M -2M
netCommonStockIssuance 217M 332M -5M -3M 76M
commonStockIssuance 221M 344M 0 0 77M
netPreferredStockIssuance 0 -344M 0 0 -77M
netDividendsPaid -303M -274M -245M -176M -152M
commonDividendsPaid -303M -274M -169M -145M -152M
preferredDividendsPaid 0 0 -76M -30M 0
otherFinancingActivities -8M 333M 221M -1M 72M
netCashProvidedByFinancingActivities 119M 23M 315M -230M -85M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 0 52M 51M 0

Earning call transcript

2025 q3
2025-10-31 ET (fiscal 2025 q3)
2025 q2
2025-07-31 ET (fiscal 2025 q2)
2025 q1
2025-05-01 ET (fiscal 2025 q1)
2024 q4
2025-02-13 ET (fiscal 2024 q4)
2024 q3
2024-10-30 ET (fiscal 2024 q3)
2024 q2
2024-08-01 ET (fiscal 2024 q2)
2024 q1
2024-05-02 ET (fiscal 2024 q1)
2023 q4
2024-02-15 ET (fiscal 2023 q4)
2023 q3
2023-11-02 ET (fiscal 2023 q3)
2023 q2
2023-08-03 ET (fiscal 2023 q2)
2023 q1
2023-05-04 ET (fiscal 2023 q1)
2022 q4
2023-02-16 ET (fiscal 2022 q4)
2022 q3
2022-11-02 ET (fiscal 2022 q3)
2022 q2
2022-07-28 ET (fiscal 2022 q2)
2022 q1
2022-05-05 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2026-07-30 ET
Hercules Capital Reports Second Quarter 2026 Financial Results
2026-07-28 ET
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Second Quarter 2026
2026-07-24 ET
Hercules Capital Closes Institutional Notes Offering of $325.0 Million 6.300% Unsecured Notes due 2031
2026-07-21 ET
Hercules Capital Prices Institutional Notes Offering of $325.0 Million 6.300% Notes due 2031
2026-07-16 ET
Hercules Capital Announces Date for Release of Second Quarter 2026 Financial Results and Conference Call
2026-06-17 ET
Behavox Raises $175 Million from HPS Investment Partners, Part of BlackRock, to Accelerate Global Growth
2026-06-17 ET
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
2026-05-07 ET
Hercules Capital Announces Date of 2026 Annual Meeting of Stockholders
2026-05-05 ET
Hercules Capital Reports First Quarter 2026 Financial Results
2026-05-04 ET
Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
2026-05-04 ET
Hercules Capital Enters Next Phase of Growth with Expanded Leadership Team
2026-04-30 ET
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2026
2026-04-21 ET
Hercules Capital Announces Date for Release of First Quarter 2026 Financial Results and Conference Call
2026-04-06 ET
Hercules Capital Sets New Record with All-Time High New Debt and Equity Commitments
2026-03-18 ET
HTGC Investors Have Opportunity to Join Hercules Capital, Inc. Fraud Investigation with the Schall Law Firm
2026-03-17 ET
HERCULES INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Hercules Capital, Inc. on Behalf of Hercules Stockholders and Encourages Investors to Contact the Firm
2026-03-04 ET
Hercules Capital Receives a BBB (high) Affirmed Investment Grade Corporate and Credit Rating from Morningstar DBRS
2026-03-02 ET
Hercules Capital, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
2026-03-02 ET
Hercules Capital Named 2025 Americas BDC Manager of the Year by Private Debt Investor
2026-02-12 21:05 ET
Hercules Capital Reports Fourth Quarter and Full-Year 2025 Financial Results
2026-02-10 18:06 ET
Hercules Capital Closes Institutional Notes Offering of $300.0 Million 5.350% Unsecured Notes due 2029
2026-02-10 11:01 ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.28 per Share
2026-02-10 11:00 ET
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Fourth Quarter 2025
2026-02-05 21:05 ET
Hercules Capital Prices Institutional Notes Offering of $300.0 Million 5.350% Notes due 2029
2026-01-29 ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2025 Financial Results and Conference Call
2026-01-27 ET
Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*
2026-01-20 ET
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
2025-11-11 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2025-10-30 ET
Hercules Capital Reports Third Quarter 2025 Financial Results
2025-10-28 ET
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Third Quarter 2025
2025-10-27 ET
Hercules Capital Celebrates $25.0 Billion Milestone in Total Cumulative Debt Commitments
2025-10-16 ET
Hercules Capital Announces Date for Release of Third Quarter 2025 Financial Results and Conference Call
2025-09-24 ET
Tipalti Secures $200 Million in Growth Financing to Drive Next Wave of AI Innovation in Finance
2025-09-18 ET
Hercules Capital Receives Investment Grade Rating Upgrade to Baa2 With Revised Outlook to Stable From Moody’s Investors Service
2025-09-03 ET
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
2025-08-19 ET
Hercules Capital Receives a BBB+ Affirmed Investment Grade Corporate and Credit Rating from Kroll Bond Rating Agency, Inc.
2025-08-05 ET
Snappt Acquires Trigo to Enhance Applicant Trust Platform for Multifamily Housing, Secures $50M Growth Financing
2025-07-31 ET
Hercules Capital Reports Second Quarter 2025 Financial Results
2025-07-29 ET
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Second Quarter 2025
2025-07-28 ET
Hercules Capital’s Wholly-Owned Investment Adviser Launches Fourth Institutional Private Credit Fund
2025-07-17 ET
Hercules Capital Announces Date for Release of Second Quarter 2025 Financial Results and Conference Call
2025-07-01 ET
Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.
2025-06-30 ET
Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
2025-06-16 ET
Hercules Capital Closes Upsized Institutional Notes Offering of $350.0 Million 6.000% Unsecured Notes due 2030
2025-06-12 ET
Hercules Capital Renews and Increases Its Credit Facility with MUFG Bank, Ltd. to $440.0 Million
2025-06-11 ET
Hercules Capital Prices Upsized Institutional Notes Offering of $350.0 Million 6.000% Notes due 2030
2025-05-08 ET
Hercules Capital Announces Date of 2025 Annual Meeting of Stockholders
2025-05-01 ET
Hercules Capital Reports First Quarter 2025 Financial Results
2025-04-29 ET
Hercules Capital Declares a Total Cash Distribution of $0.47 Per Share for the First Quarter 2025
2025-04-17 ET
Hercules Capital Announces Date for Release of First Quarter 2025 Financial Results and Conference Call
2025-04-16 ET
Correction: Hercules Capital Receives Secured Debt Rating Upgrade to BBB from Fitch Ratings, Inc.
2025-04-16 ET
Hercules Capital Receives Investment Grade Rating Upgrade to BBB from Fitch Ratings, Inc.
2025-03-26 ET
Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital
2025-03-10 ET
Hercules Capital Closes Offering of $287.5 Million of Convertible Unsecured Notes
2025-03-07 ET
Hercules Capital Receives Investment Grade Rating Upgrade to BBB (high) with Revised Outlook to Stable from Morningstar DBRS
2025-03-06 ET
KBRA Assigns Rating to Hercules Capital, Inc.'s $250 Million Convertible Unsecured Notes Due 2028
2025-03-05 ET
Hercules Capital Prices $250.0 Million of Convertible Unsecured Notes
2025-03-05 ET
Hercules Capital Announces Offering of $250.0 Million of Convertible Unsecured Notes
2025-02-13 ET
Hercules Capital Reports Fourth Quarter and Full-Year 2024 Financial Results
2025-02-11 ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.28 per Share
2025-02-11 ET
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Fourth Quarter 2024
2025-01-30 ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2024 Financial Results and Conference Call
2024-12-19 ET
Remodel Health Raises More Than $100 Million to Continue Expansion in ICHRA Market
2024-12-02 ET
Hercules Capital Renews and Increases Its Multi-Currency SMBC Credit Facility to $300.0 Million
2024-11-08 ET
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
2024-10-30 20:07 ET
Hercules Capital Reports Third Quarter 2024 Financial Results
2024-10-28 10:00 ET
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Third Quarter 2024
2024-10-17 10:00 ET
Hercules Capital Announces Date for Release of Third Quarter 2024 Financial Results and Conference Call
2024-10-09 10:00 ET
Hercules Capital Receives Reaffirmed Baa3 Investment Grade Rating with Revised Outlook to Positive from Moody’s Investors Service
2024-09-25 10:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2024-08-27 20:05 ET
Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital
2024-08-19 20:05 ET
Hercules Capital Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
2024-08-01 20:07 ET
Hercules Capital Reports Second Quarter 2024 Financial Results
2024-07-31 15:00 ET
Thumbtack Announces $75 Million in Financing from Silicon Valley Bank and Hercules Capital
2024-07-30 10:00 ET
Hercules Capital Declares a Total Cash Distribution of $0.48 Per Share for the Second Quarter 2024
2024-07-18 10:00 ET
Hercules Capital Announces Date for Release of Second Quarter 2024 Financial Results and Conference Call
2024-07-17 13:00 ET
Pindrop Secures $100 Million Financing To Accelerate Fraud And Deepfake Detection Technologies
2024-07-17 10:00 ET
Hercules Capital Receives SBA Approval for Its Fourth SBIC License
2024-06-24 10:45 ET
NeueHealth Secures up to $150 Million in New Term Loan Facility with Hercules Capital
2024-05-15 11:00 ET
Adaptimmune Secures up to $125 Million Debt Financing with Hercules Capital
2024-05-13 10:00 ET
Hercules Capital Announces Date of 2024 Annual Meeting of Stockholders
2024-05-09 11:00 ET
Electric Hydrogen secures $100M credit facility from HSBC, J.P. Morgan, Stifel Bank and Hercules Capital to decarbonize critical industries at scale
2024-05-09 10:30 ET
X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
2024-05-07 10:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2024-05-02 20:05 ET
Hercules Capital Reports First Quarter 2024 Financial Results
2024-04-30 10:00 ET
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024
2024-04-30 10:00 ET
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024
2024-04-30 07:00 ET
SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab
2024-04-30 07:00 ET
SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab
2024-04-24 10:00 ET
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations
2024-04-24 10:00 ET
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations
2024-04-18 10:00 ET
Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call
2024-03-27 10:00 ET
Hercules Capital Receives BBB- Affirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
2024-03-21 10:00 ET
Hercules Capital Receives Confirmed BBB Investment Grade Rating with Revised Outlook to Positive from Morningstar DBRS
2024-03-18 12:00 ET
bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital
2024-02-20 11:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2024-02-15 21:07 ET
Hercules Capital Reports Fourth Quarter and Full-Year 2023 Financial Results
2024-02-13 11:02 ET
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Fourth Quarter 2023
2024-02-13 11:02 ET
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Fourth Quarter 2023
2024-02-13 11:00 ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 per Share
2024-02-13 11:00 ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 per Share
2024-01-25 11:00 ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2023 Financial Results and Conference Call
2024-01-02 07:00 ET
Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital
2024-01-02 ET
Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital
2023-12-22 22:00 ET
enGene Announces Expanded $50 Million Debt Facility with Hercules Capital
2023-12-22 ET
enGene Announces Expanded $50 Million Debt Facility with Hercules Capital
2023-12-14 13:00 ET
Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital
2023-11-09 21:10 ET
Hercules Capital Receives SBA “Green Light” Letter to Submit Its Fourth SBIC License Application
2023-11-08 11:00 ET
Hercules Capital Announces Upcoming Events for the Financial Community
2023-11-02 20:10 ET
Hercules Capital Reports Third Quarter 2023 Financial Results
2023-10-31 10:00 ET
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Third Quarter 2023
2023-10-31 ET
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Third Quarter 2023
2023-10-12 10:00 ET
Hercules Capital Announces Date for Release of Third Quarter 2023 Financial Results and Conference Call
2023-10-04 10:00 ET
Hercules Capital Receives Reaffirmed Baa3 Investment Grade Credit and Corporate Rating from Moody’s Investors Service
2023-09-25 10:00 ET
Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors
2023-08-31 10:00 ET
Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
2023-08-08 00:42 ET
Hercules Capital, Inc. Prices Upsized Public Offering of Common Stock
2023-08-07 20:17 ET
Hercules Capital, Inc. Announces Public Offering of Common Stock
2023-08-03 20:10 ET
Hercules Capital Reports Second Quarter 2023 Financial Results
2023-08-03 12:00 ET
X4 Pharmaceuticals Closes $115 Million Loan Facility with Hercules Capital
2023-08-03 ET
X4 Pharmaceuticals Closes $115 Million Loan Facility with Hercules Capital
2023-08-01 10:00 ET
Hercules Capital Increases Its Total Cash Distribution to $0.48 per Share for the Second Quarter 2023
2023-07-10 10:00 ET
Hercules Capital Announces Date for Release of Second Quarter 2023 Financial Results and Conference Call
2023-05-15 15:00 ET
Tipalti Secures $150 Million in Growth Financing from JPMorgan Chase Bank and Hercules Capital
2023-05-11 10:00 ET
Hercules Capital Announces Date of 2023 Annual Meeting of Stockholders
2023-05-04 20:10 ET
Hercules Capital Reports First Quarter 2023 Financial Results
2023-05-02 10:00 ET
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2023
2023-04-20 10:00 ET
Hercules Capital Announces Date for Release of First Quarter 2023 Financial Results and Conference Call
2023-04-04 10:00 ET
Hercules Capital Receives BBB- Reaffirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
2023-03-27 10:00 ET
Hercules Adviser LLC Establishes A New Institutional Private Credit Lending Program
2023-03-22 10:00 ET
Hercules Capital Increases Its Committed Letter of Credit Facility with SMBC
2023-03-14 14:02 ET
EPAM Welcomes DeAnne Aguirre to its Board of Directors
2023-03-14 12:05 ET
Gibraltar Business Capital Launches Gibraltar Equipment Finance
2023-03-13 10:00 ET
Hercules Capital Business Update and Response to the Closure of Silicon Valley Bank
2023-02-24 11:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2023-02-16 21:10 ET
Hercules Capital Reports Fourth Quarter and Full-Year 2022 Financial Results
2023-02-14 11:03 ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 per Share
2023-02-14 11:00 ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.39 per Share for the Fourth Quarter of 2022
2023-02-02 21:01 ET
Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD®
2023-02-02 11:00 ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2022 Financial Results and Conference Call
2022-12-07 11:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2022-11-16 11:00 ET
Hercules Capital Announces Upcoming Events for the Financial Community
2022-11-02 20:05 ET
Hercules Capital Reports Third Quarter 2022 Financial Results
2022-10-19 20:05 ET
Tricida Announces $125 Million Debt Facility with Hercules Capital
2022-10-19 10:00 ET
Hercules Capital Announces Date for Release of Third Quarter 2022 Financial Results and Conference Call
2022-10-18 10:03 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Third Quarter of 2022
2022-10-18 10:00 ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.36 per Share for the Third Quarter of 2022
2022-10-07 12:00 ET
Replimune Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
2022-10-03 13:00 ET
Automation Anywhere Secures $200 Million in Financing from Silicon Valley Bank and Hercules Capital
2022-09-13 10:00 ET
Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
2022-08-31 22:12 ET
Provention Bio Announces $125 Million Term Loan Facility with Hercules Capital
2022-08-30 11:00 ET
Alladapt Announces Loan Agreement with Hercules Capital
2022-07-28 20:10 ET
Hercules Capital Reports Second Quarter 2022 Financial Results
2022-07-26 10:03 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Second Quarter of 2022
2022-07-26 10:00 ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.35 per Share for the Second Quarter of 2022
2022-07-14 10:00 ET
Hercules Capital Announces Date for Release of Second Quarter 2022 Financial Results and Conference Call
2022-06-30 20:15 ET
Geron Corporation Announces Expansion of Existing Loan Facility
2022-06-24 10:00 ET
Hercules Capital Announces the Appointment of Ms. DeAnne Aguirre to Its Board of Directors
2022-06-23 20:10 ET
Hercules Capital Completes Two Institutional Debt Financings, Raising a Total of $200.0 Million to Support Continued Growth
2022-06-16 11:00 ET
Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million
2022-06-15 10:00 ET
Hercules Capital Expands Its Credit Facilities to $720 Million to Support Strong Investment Portfolio Growth
2022-05-10 10:00 ET
Hercules Capital Receives BBB- Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
2022-05-09 10:00 ET
Hercules Capital Announces Date of 2022 Annual Meeting of Stockholders
2022-05-05 20:10 ET
Hercules Capital Reports First Quarter 2022 Financial Results
2022-05-03 10:03 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the First Quarter of 2022
2022-05-03 10:00 ET
Hercules Capital Declares Cash Distribution of $0.33 per Share for the First Quarter of 2022
2022-04-18 10:00 ET
Hercules Receives a BBB Reaffirmed Investment Grade Corporate Rating From DBRS, Inc.
2022-04-14 10:00 ET
Hercules Capital Announces Date for Release of First Quarter 2022 Financial Results and Conference Call
2022-03-01 11:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2022-02-22 21:10 ET
Hercules Capital Reports Fourth Quarter and Full-Year 2021 Financial Results
2022-02-22 11:02 ET
Hercules Capital Announces New Supplemental Cash Distribution of $0.60 per Share
2022-02-22 11:00 ET
Hercules Capital Declares Cash Distribution of $0.33 per Share for the Fourth Quarter of 2021
2022-02-08 11:00 ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2021 Financial Results and Conference Call
2022-02-02 12:00 ET
Tarsus Completes Enrollment for the Pivotal Phase 3 Saturn-2 Trial of TP-03 to Treat Demodex Blepharitis and Secures $175 Million Credit Facility
2022-02-01 11:00 ET
Hercules Capital Enhances C-Suite for Future Growth
2022-01-20 15:35 ET
Hercules Capital Closes Upsized Public Offering of $350.0 Million 3.375% Notes Due 2027
2022-01-14 22:33 ET
Hercules Capital Prices Upsized Public Offering of $350.0 Million 3.375% Notes due 2027
2021-12-17 12:00 ET
NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders
2021-11-29 11:00 ET
Hercules Capital Surpasses $2.0 Billion in Annual Gross Debt and Equity Commitments for First Time in History
2021-11-10 11:00 ET
Hercules Capital Further Strengthens Its Capital Resources With New $100.0 Million Multi-Currency Credit Facility
2021-11-09 21:10 ET
Hercules Capital Announces Upcoming Events for the Financial Community
2021-10-28 20:10 ET
Hercules Capital Reports Third Quarter 2021 Financial Results
2021-10-26 10:03 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.07 per Share for the Third Quarter of 2021
2021-10-26 10:00 ET
Hercules Capital Increases Its Quarterly Cash Distribution to $0.33 per Share for the Third Quarter of 2021
2021-10-20 10:00 ET
Hercules Capital Announces the Appointment of Ms. Pam Randhawa to Its Board of Directors
2021-10-19 11:30 ET
Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital
2021-10-14 10:00 ET
Hercules Capital Announces Date for Release of Third Quarter 2021 Financial Results and Conference Call
2021-10-05 12:00 ET
Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from Hercules Capital
2021-09-27 12:00 ET
Corium Secures $235 Million in Debt Financing
2021-09-27 10:00 ET
Hercules Capital Delivers a New Record by Surpassing $1.5 Billion of Annual Gross Debt and Equity Commitments
2021-09-20 12:00 ET
Phathom Pharmaceuticals Secures $200 Million Term Loan Facility from Hercules Capital
2021-09-16 20:10 ET
Hercules Capital Closes Public Offering of $325.0 Million 2.625% Notes due 2026
2021-09-13 20:41 ET
Hercules Capital Prices Public Offering of $325.0 Million 2.625% Notes Due 2026
2021-08-25 12:00 ET
Better Therapeutics Secures $50 Million Debt Facility From Hercules Capital
2021-08-02 10:00 ET
Hercules Capital Reaches $1.0 Billion Milestone in Annual Debt and Equity Commitments for the Fourth Consecutive Year
2021-07-29 20:10 ET
Hercules Capital Reports Second Quarter 2021 Financial Results
2021-07-27 10:01 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.07 Per Share for the Second Quarter Of 2021
2021-07-27 10:00 ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the Second Quarter of 2021
2021-07-15 10:00 ET
Hercules Capital Announces Date for Release of Second Quarter 2021 Financial Results and Conference Call
2021-06-25 17:23 ET
Hercules Capital Announces the Appointment of Wade Loo to Its Board of Directors
2021-06-08 10:00 ET
Hercules Capital Announces Date of 2021 Annual Meeting of Stockholders
2021-06-03 11:01 ET
Nabriva Agrees to Extension of Principal Debt Repayments Under Existing Loan Agreement with Hercules Capital
2021-05-28 17:05 ET
Hercules Capital Announces Its Intention to Fully Redeem its 5.25% Notes due 2025
2021-05-19 12:00 ET
HiberCell Closes $67.4 Million Series B Financing and Secures $30 Million Debt Facility from Hercules Capital
2021-05-14 12:30 ET
SCYNEXIS Secures Term Loan Facility for up to $60 Million with Hercules Capital and Silicon Valley Bank
2021-05-12 14:35 ET
Gibraltar Business Capital Announces $150MM Line of Credit with Bank of America
2021-04-29 20:10 ET
Hercules Capital Reports First Quarter 2021 Financial Results
2021-04-27 10:03 ET
Hercules Capital Announces Fiscal 2021 Supplemental Cash Distribution of $0.28 Per Share
2021-04-27 10:00 ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the First Quarter of 2021
2021-04-15 10:00 ET
Hercules Capital Announces Date for Release of First Quarter 2021 Financial Results and Conference Call
2021-03-25 10:00 ET
Hercules Adviser LLC Announces the Closing of Its Inaugural Institutional Private Credit Fund
2021-03-08 11:00 ET
Hercules Capital Receives Baa3 Investment Grade Credit and Corporate Rating from Moody’s Investors Service
2021-03-04 21:21 ET
Hercules Capital Completes Investment Grade Bond Offering of $50.0 Million of 4.55% Notes due March 2026
2021-03-02 11:00 ET
Hercules Capital Announces Upcoming Event for the Financial Community
2021-02-23 21:10 ET
Hercules Capital Reports Fourth Quarter and Full-Year 2020 Financial Results
2021-02-22 11:02 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.05 per Share for the Fourth Quarter of 2020
2021-02-22 11:00 ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the Fourth Quarter of 2020
2021-02-09 11:00 ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2020 Financial Results and Conference Call
2020-11-18 15:00 ET
CloudBolt Announces $35 Million in Series B Funding Led by Insight Partners
2020-11-04 22:03 ET
Hercules Capital Announces an Investment Grade Bond Offering Totaling $100.0 Million Due 2026
2020-11-03 16:57 ET
Udacity Drives 120% Enterprise and Government Growth in Q3, Secures $75 Million to Continue Momentum
2020-10-29 20:10 ET
Hercules Capital Reports Third Quarter 2020 Financial Results
2020-10-28 20:10 ET
Hercules Capital Gains Additional Liquidity for New Investments with Approval of Third SBA License
2020-10-27 10:02 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.02 per Share for the Third Quarter of 2020
2020-10-27 10:00 ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the Third Quarter of 2020
2020-10-22 10:00 ET
Hercules Capital Announces Date for Release of Third Quarter 2020 Financial Results and Conference Call
2020-10-01 20:30 ET
Geron Secures Loan Facility for Up to $75 Million
2020-08-04 20:05 ET
UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital
2020-07-30 20:10 ET
Hercules Capital Reports Second Quarter 2020 Financial Results
2020-07-29 10:00 ET
Hercules Capital Surpasses $1.0 Billion in Cumulative Distributions to Shareholders since IPO
2020-07-22 20:10 ET
Hercules Capital Announces Date for Release of Second Quarter 2020 Financial Results and Conference Call
2020-06-08 10:00 ET
Hercules Capital Receives SBA “Green Light” Letter Approval to Complete Its Third SBIC License
2020-06-03 20:10 ET
Hercules Capital Completes 5-Year Investment Grade Bond Offering of $70.0 Million of 4.31% Notes due June 2025
2020-05-04 20:10 ET
Hercules Capital Reports First Quarter 2020 Financial Results
2020-05-01 10:00 ET
Hercules Capital Declares Cash Distribution of $0.32 per Share for the First Quarter of 2020
2020-04-27 10:00 ET
Hercules Capital Announces Date of 2020 Annual Meeting of Stockholders and Special Meeting of Stockholders
2020-04-16 10:00 ET
Hercules Capital Announces Date for Release of First Quarter 2020 Financial Results and Conference Call
2020-03-23 10:00 ET
Hercules Capital Business and Coronavirus Update
2020-02-20 21:10 ET
Hercules Capital Reports Fourth Quarter and Record Full-Year 2019 Financial Results
2020-02-20 11:00 ET
Hercules Capital Strengthens Its Capital Resources with New $400.0 Million Credit Facility to Support Continued Investment Portfolio Growth
2020-02-19 21:12 ET
Hercules Capital Announces Supplemental Cash Distribution of $0.08 per Share for the Fourth Quarter of 2019
2020-02-19 21:10 ET
Hercules Capital Declares Distribution of $0.32 per Share for the Fourth Quarter of 2019
2020-02-06 11:00 ET
Hercules Capital Announces 5-Year Investment Grade Bond Offering Totaling $120.0 Million
2020-01-30 11:00 ET
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2019 Financial Results and Conference Call
2020-01-14 11:00 ET
Hercules Capital Reaches $10.0 Billion Milestone in Total Debt Commitments Since Inception
2020-01-08 11:00 ET
Hercules Capital Highlights 2019 Achievements, Setting a New Investment Record with $1.47 Billion in Total New Debt and Equity Commitments

SEC forms

Show financial reports only

SEC form 10
2026-10-29 00:00 ET
Hercules Capital published news for 2026 q3
SEC form 8
2026-10-29 00:00 ET
Hercules Capital published news for 2026 q3
SEC form 8
2026-10-29 00:00 ET
Hercules Capital published news for 2026 q3
SEC form 8
2026-10-29 00:00 ET
Hercules Capital published news for 2026 q3
SEC form 8
2026-07-30 20:30 ET
Hercules Capital published news for 2026 q2
SEC form 8
2026-07-30 20:30 ET
Hercules Capital published news for 2026 q2
SEC form 8
2026-07-30 20:30 ET
Hercules Capital published news for 2026 q2
SEC form 10
2026-07-30 20:17 ET
Hercules Capital published news for 2026 q2
SEC form 8
2026-07-21 12:44 ET
Hercules Capital published news for 2026 q2
SEC form 8
2026-06-18 20:30 ET
Hercules Capital published news for 2026 q1
SEC form 8
2026-05-05 20:30 ET
Hercules Capital published news for 2026 q1
SEC form 8
2026-05-05 20:30 ET
Hercules Capital published news for 2026 q1
SEC form 8
2026-05-05 20:30 ET
Hercules Capital published news for 2026 q1
SEC form 10
2026-05-05 20:17 ET
Hercules Capital published news for 2026 q1
SEC form 8
2026-02-12 16:30 ET
Hercules Capital published news for 2025 q4
SEC form 8
2026-02-12 16:30 ET
Hercules Capital published news for 2025 q4
SEC form 8
2026-02-12 16:30 ET
Hercules Capital published news for 2025 q4
SEC form 8
2026-02-12 16:30 ET
Hercules Capital published news for 2025 q4
SEC form 10
2026-02-12 16:17 ET
Hercules Capital published news for 2025 q4
SEC form 8
2026-02-03 14:00 ET
Hercules Capital published news for 2025 q4
SEC form 8
2025-10-30 20:30 ET
Hercules Capital published news for 2025 q3
SEC form 8
2025-10-30 20:30 ET
Hercules Capital published news for 2025 q3
SEC form 8
2025-10-30 20:30 ET
Hercules Capital published news for 2025 q3
SEC form 10
2025-10-30 20:17 ET
Hercules Capital published news for 2025 q3
SEC form 8
2025-07-31 20:30 ET
Hercules Capital published news for 2025 q2
SEC form 8
2025-07-31 20:30 ET
Hercules Capital published news for 2025 q2
SEC form 8
2025-07-31 20:30 ET
Hercules Capital published news for 2025 q2
SEC form 10
2025-07-31 20:17 ET
Hercules Capital published news for 2025 q2
SEC form 8
2025-06-20 20:17 ET
Hercules Capital published news for 2025 q1
SEC form 8
2025-05-01 20:30 ET
Hercules Capital published news for 2025 q1
SEC form 8
2025-05-01 20:30 ET
Hercules Capital published news for 2025 q1
SEC form 8
2025-05-01 20:30 ET
Hercules Capital published news for 2025 q1
SEC form 10
2025-05-01 20:16 ET
Hercules Capital published news for 2025 q1
SEC form 10
2025-05-01 00:00 ET
Hercules Capital published news for 2025 q1
SEC form 8
2025-03-06 01:35 ET
Hercules Capital published news for 2024 q4
SEC form 8
2025-03-06 01:35 ET
Hercules Capital published news for 2024 q4
SEC form 8
2025-03-05 12:53 ET
Hercules Capital published news for 2024 q4
SEC form 8
2025-03-05 12:53 ET
Hercules Capital published news for 2024 q4
SEC form 8
2025-02-13 16:30 ET
Hercules Capital published news for 2024 q4
SEC form 8
2025-02-13 16:30 ET
Hercules Capital published news for 2024 q4
SEC form 8
2025-02-13 16:30 ET
Hercules Capital published news for 2024 q4
SEC form 8
2025-02-13 16:30 ET
Hercules Capital published news for 2024 q4
SEC form 10
2025-02-13 16:16 ET
Hercules Capital published news for 2024 q4
SEC form 10
2025-02-13 00:00 ET
Hercules Capital published news for 2024 q4
SEC form 8
2024-10-30 16:30 ET
Hercules Capital published news for 2024 q3
SEC form 8
2024-10-30 16:30 ET
Hercules Capital published news for 2024 q3
SEC form 8
2024-10-30 16:30 ET
Hercules Capital published news for 2024 q3
SEC form 10
2024-10-30 16:16 ET
Hercules Capital published news for 2024 q3
SEC form 10
2024-10-30 00:00 ET
Hercules Capital published news for 2024 q3
SEC form 8
2024-08-01 16:20 ET
Hercules Capital published news for 2024 q2
SEC form 8
2024-08-01 16:20 ET
Hercules Capital published news for 2024 q2
SEC form 8
2024-08-01 16:20 ET
Hercules Capital published news for 2024 q2
SEC form 10
2024-08-01 16:16 ET
Hercules Capital published news for 2024 q2
SEC form 10
2024-08-01 00:00 ET
Hercules Capital published news for 2024 q2
SEC form 8
2024-05-02 16:31 ET
Hercules Capital published news for 2024 q1
SEC form 8
2024-05-02 16:31 ET
Hercules Capital published news for 2024 q1
SEC form 8
2024-05-02 16:31 ET
Hercules Capital published news for 2024 q1
SEC form 10
2024-05-02 16:17 ET
Hercules Capital published news for 2024 q1
SEC form 10
2024-05-02 00:00 ET
Hercules Capital published news for 2024 q1
SEC form 10
2024-02-15 00:00 ET
Hercules Capital published news for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Hercules Capital published news for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Hercules Capital published news for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Hercules Capital published news for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Hercules Capital published news for 2023 q4
SEC form 8
2023-11-02 16:22 ET
Hercules Capital published news for 2023 q3
SEC form 10
2023-11-02 16:15 ET
Hercules Capital published news for 2023 q3
SEC form 10
2023-11-02 00:00 ET
Hercules Capital published news for 2023 q3
SEC form 6
2023-08-03 16:30 ET
Hercules Capital published news for 2023 q2
SEC form 10
2023-08-03 16:18 ET
Hercules Capital reported for 2023 q2
SEC form 10
2023-08-03 00:00 ET
Hercules Capital reported for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Hercules Capital published news for 2023 q2
SEC form 6
2023-07-20 16:30 ET
Hercules Capital published news for 2023 q2
SEC form 6
2023-06-23 16:30 ET
Hercules Capital published news for 2023 q1
SEC form 10
2023-05-04 00:00 ET
Hercules Capital published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Hercules Capital published news for 2023 q1
SEC form 6
2023-03-13 07:51 ET
Hercules Capital published news for 2022 q4
SEC form 6
2023-02-16 16:20 ET
Hercules Capital published news for 2022 q4
SEC form 10
2023-02-16 16:08 ET
Hercules Capital reported for 2022 q4
SEC form 10
2023-02-16 00:00 ET
Hercules Capital reported for 2022 q4
SEC form 8
2023-02-16 00:00 ET
Hercules Capital published news for 2022 q4
SEC form 6
2023-01-27 16:30 ET
Hercules Capital published news for 2022 q4
SEC form 6
2023-01-17 07:22 ET
Hercules Capital published news for 2022 q4
SEC form 6
2022-11-02 16:17 ET
Hercules Capital published news for 2022 q3
SEC form 10
2022-11-02 16:08 ET
Hercules Capital published news for 2022 q3
SEC form 10
2022-11-02 00:00 ET
Hercules Capital published news for 2022 q3
SEC form 8
2022-11-02 00:00 ET
Hercules Capital published news for 2022 q3
SEC form 6
2022-10-18 06:30 ET
Hercules Capital published news for 2022 q3
SEC form 6
2022-07-28 16:30 ET
Hercules Capital published news for 2022 q2
SEC form 10
2022-07-28 16:16 ET
Hercules Capital published news for 2022 q2
SEC form 6
2022-06-27 08:59 ET
Hercules Capital published news for 2022 q1
SEC form 6
2022-06-15 16:32 ET
Hercules Capital published news for 2022 q1
SEC form 6
2022-05-09 17:22 ET
Hercules Capital published news for 2022 q1
SEC form 6
2022-05-05 16:31 ET
Hercules Capital published news for 2022 q1
SEC form 10
2022-05-05 16:27 ET
Hercules Capital published news for 2022 q1
SEC form 6
2022-04-29 16:30 ET
Hercules Capital published news for 2022 q1
SEC form 10
2022-02-22 16:31 ET
Hercules Capital published news for 2021 q4
SEC form 6
2022-02-22 16:30 ET
Hercules Capital published news for 2021 q4
SEC form 6
2022-02-01 06:08 ET
Hercules Capital published news for 2021 q4
SEC form 6
2022-01-21 16:18 ET
Hercules Capital published news for 2021 q4
SEC form 6
2022-01-21 08:01 ET
Hercules Capital published news for 2021 q4
SEC form 6
2022-01-18 17:07 ET
Hercules Capital published news for 2021 q4
SEC form 6
2022-01-10 06:08 ET
Hercules Capital published news for 2021 q4
SEC form 6
2021-11-29 17:05 ET
Hercules Capital published news for 2021 q3
SEC form 6
2021-11-10 07:07 ET
Hercules Capital published news for 2021 q3
SEC form 6
2021-10-28 16:42 ET
Hercules Capital published news for 2021 q3
SEC form 10
2021-10-28 16:30 ET
Hercules Capital published news for 2021 q3
SEC form 6
2021-10-20 08:46 ET
Hercules Capital published news for 2021 q3
SEC form 6
2021-09-24 16:01 ET
Hercules Capital published news for 2021 q2
SEC form 6
2021-09-16 17:28 ET
Hercules Capital published news for 2021 q2
SEC form 6
2021-09-15 06:10 ET
Hercules Capital published news for 2021 q2
SEC form 6
2021-07-29 16:40 ET
Hercules Capital published news for 2021 q2
SEC form 10
2021-07-29 16:32 ET
Hercules Capital published news for 2021 q2
SEC form 6
2021-07-13 16:30 ET
Hercules Capital published news for 2021 q2
SEC form 6
2021-06-25 16:45 ET
Hercules Capital published news for 2021 q1
SEC form 6
2021-05-28 17:00 ET
Hercules Capital published news for 2021 q1
SEC form 6
2021-04-29 16:40 ET
Hercules Capital published news for 2021 q1
SEC form 10
2021-04-29 16:30 ET
Hercules Capital published news for 2021 q1
SEC form 6
2021-04-27 16:31 ET
Hercules Capital published news for 2021 q1
SEC form 6
2021-03-08 07:00 ET
Hercules Capital published news for 2020 q4
SEC form 6
2021-03-04 16:48 ET
Hercules Capital published news for 2020 q4
SEC form 6
2021-02-23 16:40 ET
Hercules Capital published news for 2020 q4
SEC form 10
2021-02-23 16:31 ET
Hercules Capital published news for 2020 q4
SEC form 6
2021-02-12 16:19 ET
Hercules Capital published news for 2020 q4
SEC form 6
2020-11-04 17:11 ET
Hercules Capital published news for 2020 q3
SEC form 6
2020-10-29 16:40 ET
Hercules Capital published news for 2020 q3
SEC form 10
2020-10-29 16:30 ET
Hercules Capital published news for 2020 q3
SEC form 6
2020-10-28 16:21 ET
Hercules Capital published news for 2020 q3